Tanzania Pharma Registration: TMDA Requirements 2026

The Tanzania Medicines and Medical Devices Authority (TMDA)

TMDA is the national regulatory authority for medicines, medical devices, and diagnostics in Tanzania Mainland. It operates under the Ministry of Health, Community Development, Gender, Elderly and Children.

TMDA's core functions:

• Product registration and licensing for human and veterinary medicines
• Inspecting manufacturing facilities (GMP audits)
• Issuing import and export permits
• Pharmacovigilance and post-market surveillance
• Clinical trial authorization
• Regulating medical devices and diagnostics

TMDA has its headquarters in Dar es Salaam (at the iconic TFDA building in Mabibo) and zonal offices in Arusha, Mwanza, Mbeya, and Mtwara. The authority has embraced digital transformation with an online portal called the TMDA Integrated Management System (IMS), where all submissions and payments are processed.

Registration Classes & Product Categories

TMDA classifies pharmaceutical products into different registration pathways based on risk and product type.

Class A: New Chemical Entities (NCEs)

Full clinical trial data required. Timeline: 12-24 months. This pathway is rare for most generic exporters. Cost: $5,000-$15,000.

Class B: Generic Products (Full Dossier)

The most common pathway for imported generics. Requires bioequivalence data or a BCS-based biowaiver. Timeline: 8-14 months. Cost: $2,000-$5,000 in official fees plus consultant costs.

Class C: Abridged Applications (Well-Established Use)

For products with well-documented safety and efficacy (e.g., WHO Essential Medicines List). Reduced dossier requirements. Timeline: 6-10 months.

Class D: Over-the-Counter (OTC) & Herbal Products

Simplified documentation. No bioequivalence studies required. Timeline: 5-8 months.

Class E: EAC Joint Assessment Procedure (JAP)

Regional pathway through the East African Community. One dossier assessed by multiple EAC countries. Timeline: 4-8 months for assessment, plus national steps. Highly recommended for multi-market entry.

Class F: SRA/WHO PQ Fast-Track

Products with WHO Prequalification or approval by a Stringent Regulatory Authority (US FDA, EMA, Health Canada, TGA, PMDA) qualify for accelerated review. Timeline: 3-6 months.

Class G: Locally Manufactured Products

Priority processing and reduced fees for products manufactured within Tanzania or other EAC countries.

Prerequisites: What You Need Before Applying

Before you submit anything to TMDA, make sure you have these items in place. Missing any of them will result in immediate rejection.

• Appoint a Local Authorized Representative (LAR): Foreign manufacturers cannot hold a TMDA registration. You need a Tanzanian company with a valid TMDA importer license to be your local representative. This company must have a physical address in Tanzania and a licensed pharmacist on staff.
• Execute a Power of Attorney (PoA): A notarized document authorizing your LAR to act on your behalf. Must be apostilled or legalized at the Tanzanian embassy in your country.
• Obtain a Certificate of Pharmaceutical Product (CPP): Issued by the regulatory authority in your manufacturing country. Must be in WHO format, less than 2 years old, and properly legalized. TMDA is very strict about the CPP format.
• Prepare Your GMP Evidence: A current GMP certificate from your local regulator or evidence of WHO PQ/SRA approval. TMDA accepts WHO PQ and SRA inspections as evidence of GMP compliance.
• Product Samples: TMDA typically requires 6-12 months of stability data at submission, but you'll need to provide product samples for laboratory testing when requested.

Step-by-Step Registration Process

Here's the actual process for registering a pharmaceutical product with TMDA. Follow these steps carefully.

Step 1: Local Agent Appointment & Verification

Sign a legally binding agreement with your Tanzanian LAR. Verify their TMDA importer license and confirm they have a licensed pharmacist on staff. This relationship will last the lifetime of your registration.

Step 2: Execute and Legalize Power of Attorney

Draft the PoA, have it notarized in your country, then apostilled or legalized at the Tanzanian embassy. This process can take 2-4 weeks depending on your location.

Step 3: Prepare Your Dossier in TMDA CTD Format

TMDA follows the EAC Common Technical Document (CTD) format, aligned with ICH guidelines. See the detailed dossier section below.

Step 4: Pre-Submission Meeting (Optional but Recommended)

Your LAR can request a pre-submission meeting with TMDA evaluators. This is an opportunity to clarify requirements, ask questions, and get informal feedback on your dossier plan. Costs nothing but time.

Step 5: Online Submission via TMDA IMS Portal

Your LAR logs into the TMDA Integrated Management System, uploads the dossier (PDFs, each under 25MB), and pays the application fee online via mobile money or bank transfer. You'll receive an acknowledgement receipt immediately.

Step 6: Administrative Screening (3-6 weeks)

TMDA checks for completeness. They verify:

• All required modules are present
• Documents are properly notarized and legalized
• CPP is valid (less than 2 years old, WHO format)
• PoA is valid and properly executed

If anything is missing, your application is returned with a deficiency letter. Each correction cycle adds 3-6 weeks.

Step 7: Scientific Evaluation (5-10 months)

This is the longest phase. TMDA evaluators review your dossier across multiple disciplines:

• Quality (chemistry, manufacturing, stability)
• Bioequivalence (for generics) or clinical data (for NCEs)
• Labeling and packaging

Evaluators issue queries (requests for additional information) via the IMS portal. You have 60-90 days to respond. Well-prepared dossiers might have 1-2 query cycles. Poor dossiers can have 3-5 cycles or be rejected outright.

Step 8: Laboratory Testing (1-3 months, may run concurrently)

TMDA will request product samples for testing at their laboratory in Dar es Salaam. They test for:

• Assay (active ingredient content)
• Related substances/impurities
• Dissolution (for solid oral dosage forms)
• Microbial limits

If your product fails laboratory testing, the registration is rejected. You'll need to address the quality issues and resubmit.

Step 9: GMP Inspection (If Required)

If your facility hasn't been inspected by TMDA before (or within the last 3 years), they will schedule an inspection. TMDA accepts WHO PQ and SRA inspections as evidence, potentially waiving physical inspection. See inspection section below.

Step 10: TMDA Technical Committee Approval (2-4 weeks)

Once evaluators are satisfied, your file goes to the TMDA Technical Committee. They meet monthly. Approval is typically granted if all requirements are met.

Step 11: Certificate Issuance & Gazette Publication (3-6 weeks)

Approved products receive a Certificate of Registration with a unique TMDA registration number (format: "TAN 23 XXX"). The product is published in the TMDA Gazette, which is the official public record.

Dossier Requirements: The TMDA CTD Format

TMDA follows the EAC Common Technical Document (CTD) format, which is harmonized with the ICH CTD. Here's the complete breakdown.

Module 1: Administrative Information (Country-Specific)

• Application letter on manufacturer letterhead
• Cover letter from Tanzanian LAR
• Power of Attorney (notarized, apostilled)
• Certificate of Pharmaceutical Product (WHO format, notarized, legalized, less than 2 years old)
• GMP Certificate from manufacturing country (notarized, legalized)
• Free Sale Certificate or Certificate of Export
• Manufacturing license from country of origin
• Product samples information (batch numbers, quantities, storage conditions)
• Labeling and package insert (mock-ups in English and Swahili recommended)
• Patent declaration (product doesn't infringe Tanzanian patents)

Module 2: Summaries

• Quality Overall Summary (QOS)
• Nonclinical Overview & Summary (for NCEs)
• Clinical Overview & Summary (or Bioequivalence summary for generics)

Module 3: Quality (Pharmaceutical Documentation)

• Drug substance (API): Manufacturing process, characterization, impurity profile, specifications, stability
• Drug product (finished product): Formulation, manufacturing process, specifications, excipients
• Stability data: Zone IV (hot & humid) conditions. Minimum 6 months accelerated, 12 months long-term at submission. Final registration requires 24 months long-term stability.
• Container closure system: Packaging specifications, compatibility data

Module 4: Nonclinical Reports (NCEs Only)

• Pharmacology studies
• Pharmacokinetics/ADME
• Toxicology studies (single-dose, repeat-dose, genotoxicity, reproductive, carcinogenicity as applicable)

Module 5: Clinical Reports

• For NCEs: Full clinical trial reports (Phase 1-3)
• For Generics: Bioequivalence study report comparing your product to the reference product (must be the innovator product registered in Tanzania or a WHO PQ-listed comparator)
• For BCS-based biowaivers: Justification based on BCS classification and solubility/permeability data

Local Representation Rules: The Non-Negotiables

TMDA has specific requirements for local representation that differ from other East African countries. Pay close attention here.

The Local Authorized Representative (LAR) Must:

• Be a company registered in Tanzania with a valid TMDA importer license
• Have a physical address in Tanzania (not a P.O. box)
• Employ at least one full-time pharmacist licensed by the Pharmacy Council of Tanzania
• Have appropriate storage facilities (including cold chain if handling temperature-sensitive products)
• Maintain records of all imported products for at least 5 years
• Have a pharmacovigilance system to collect and report adverse events to TMDA

The Power of Attorney (PoA) Must:

• Be specific to the product(s) being registered
• Have a validity period of at least 5 years
• State that the manufacturer authorizes the LAR to act on their behalf for registration, import, and pharmacovigilance
• Be notarized in the manufacturer's country
• Be apostilled (or legalized at the Tanzanian embassy)

What Happens If Your LAR Fails?

If your LAR loses their TMDA license, goes out of business, or fails to meet obligations, your registration is effectively dead. You cannot transfer the registration to a new LAR without going through a full variation process, which takes 3-6 months. Choose your LAR as carefully as you'd choose a business partner—because that's exactly what they are.

GMP Inspections: What to Expect

The GMP inspection is often the most stressful part of the TMDA registration process. Here's what you need to know.

When Is an Inspection Required?

• First-time registration from your facility in Tanzania
• No TMDA inspection in the last 3 years
• Serious GMP deficiencies identified in previous inspection
• Significant changes to manufacturing site or process
• TMDA's discretion (they inspect many facilities proactively)

Inspection Exemptions (No Physical Inspection Required):

• Facility has valid WHO Prequalification (WHO PQ) for the product/dosage form
• Facility has been inspected by an SRA (US FDA, EMA, Health Canada, TGA, PMDA) within the last 3 years
• Facility has a valid GMP certificate from a recognized regulatory authority (TMDA discretion)
• Product is eligible for the EAC JAP and the dossier includes recent GMP evidence

The Inspection Process:

1. TMDA notifies your LAR of the inspection date (typically 4-8 weeks notice)
2. You pay the inspection fee ($8,000-$15,000 plus travel expenses for 2-3 inspectors)
3. TMDA inspectors visit your facility for 3-5 days
4. They review your quality management system, production areas, QC lab, warehousing, water system, HVAC, and documentation
5. They issue an inspection report with findings (critical, major, minor deficiencies)
6. You submit a corrective action and preventive action (CAPA) plan within 30-60 days
7. TMDA may require a follow-up inspection for critical findings
8. If satisfactory, TMDA issues a GMP clearance letter

What TMDA Inspectors Focus On:

• Quality Management System (QMS) documentation
• Production area cleanliness and segregation
• Quality Control laboratory equipment and procedures
• Warehousing and storage conditions (temperature control)
• Water system validation and monitoring
• HVAC system and environmental monitoring
• Training records for production and QC staff
• Complaint handling and recall procedures
• Validation of manufacturing processes

Import Permits & Port Clearance (Dar es Salaam)

Registration is just the beginning. For each commercial shipment, you need a specific import permit from TMDA.

Import Permit Process:

1. Your LAR logs into the TMDA IMS portal.
2. They submit an import permit application, specifying:
   • Product name and TMDA registration number
   • Quantity (number of packs/units)
   • Batch numbers
   • Manufacturing date and expiry date
   • Port of entry (Dar es Salaam port or JKIA)
   • Expected arrival date
3. TMDA reviews and issues the import permit (typically 5-10 working days).
4. The permit is valid for that specific shipment and timeframe (usually 3-6 months).

Dar es Salaam Port Clearance:

Dar es Salaam port is East Africa's second-busiest port after Mombasa. Clearing pharmaceuticals requires coordination between:

• TMDA Port Office: Verifies import permit, takes samples, issues release order
• Tanzania Revenue Authority (TRA) Customs: Assesses and collects import duties and taxes
• Tanzania Ports Authority (TPA): Manages port operations
• Tanzania Bureau of Standards (TBS): Verifies product standards (some products)

Typical Clearance Timelines:

• Established importer, compliant product: 5-10 days
• First-time importer or random sample required: 10-20 days
• Shipment with issues: 20-45 days

Import Duties & Taxes:

• Import duty: 0-10% depending on product (finished formulations often 0% under EAC CET)
• VAT: 18% (standard rate, though some essential medicines may be exempt)
• Port service fees: Variable based on container size and storage duration

Costs, Timelines & Budget Planning

Here's the financial reality of registering with TMDA.

Official TMDA Fees (Approximate, subject to change)

• Application fee: TZS 200,000-500,000 ($80-200)
• Evaluation fee (Class B generic): TZS 1,000,000-3,000,000 ($400-1,200)
• Evaluation fee (Class A NCE): TZS 5,000,000-10,000,000 ($2,000-4,000)
• Registration certificate fee: TZS 500,000-1,000,000 ($200-400)
• Annual retention fee: TZS 300,000-800,000 ($120-320) per product per year
• Import permit fee: TZS 50,000-100,000 ($20-40) per shipment

Third-Party Costs (Your Real Expenses)

• Regulatory consultant fees: $3,000-$10,000 per product
• Document legalization/apostille: $500-$2,000
• GMP inspection (if required): $10,000-$20,000 including inspector travel
• Bioequivalence study: $50,000-$150,000 if new study needed
• Stability studies (Zone IV): $10,000-$30,000
• Laboratory testing fees (if TMDA samples): $500-$2,000 per product
• Translation services (English to Swahili for labeling): $500-$1,500

Total Estimated Cost Per Product:

• Class B (Generic, no inspection, existing BE data): $5,000-$10,000
• Class B (Generic, with GMP inspection): $15,000-$30,000
• Class F (SRA/WHO PQ Fast-Track): $3,000-$7,000
• Class E (EAC Joint Assessment): $8,000-$15,000 (but covers multiple countries)

Timelines:

• Fast-Track (SRA/WHO PQ): 3-6 months
• Class C (Abridged/Well-Established Use): 5-8 months
• Class B (Standard generic, well-prepared dossier): 8-12 months
• Class B (Poor dossier, multiple queries, inspection): 12-18 months

The Zanzibar Factor: Separate Registration Required

This is a critical point that many exporters miss. Zanzibar is a semi-autonomous island with its own regulatory authority. Registration with TMDA (Tanzania Mainland) does NOT grant you access to Zanzibar.

The Zanzibar Medicines Regulatory Board (ZMRB) is the competent authority for pharmaceuticals in Zanzibar. They have their own registration requirements, fees, and timelines.

What This Means For You:

• If you want to sell in both Tanzania Mainland and Zanzibar, you need two separate registrations (TMDA + ZMRB).
• ZMRB accepts TMDA registration as evidence but still requires their own administrative process.
• Zanzibar's market is smaller (approximately 1.8 million people), so evaluate whether the additional registration cost is worth the market opportunity.
• Some multinationals skip Zanzibar entirely and focus on Mainland Tanzania. Others register in Zanzibar first as a faster pathway (ZMRB can be quicker than TMDA for some products).

ZMRB Registration Snapshot:

• Timeline: 4-8 months
• Cost: $1,000-$3,000 per product
• Local agent required (Zanzibar-based company)
• Accepts TMDA registration as reference

EAC Harmonization: TMDA's Participation

Tanzania is a full participant in the East African Community (EAC) Medicines Regulatory Harmonization program. This is good news for exporters targeting multiple EAC countries.

How the EAC Joint Assessment Procedure (JAP) Works with TMDA:

1. You submit one dossier to the EAC Secretariat (or through a reference national regulator like TMDA itself).
2. A joint team of experts from EAC countries (including TMDA evaluators) assesses the dossier.
3. Once approved regionally, you obtain individual national registrations from each country—but the scientific assessment is done once.
4. TMDA accepts the EAC JAP assessment and typically issues the national registration within 1-3 months.

Benefits of Using EAC JAP for Tanzania:

• Faster than standalone TMDA registration (4-8 months assessment vs. 8-12 months)
• Lower total cost for multi-country entry
• One set of queries instead of multiple
• TMDA trusts the EAC joint assessment

Eligibility for EAC JAP:

• Generic essential medicines
• Products with WHO PQ or SRA approval
• Products on the EAC Common List of Essential Medicines

Common Pitfalls & Rejection Reasons

Based on TMDA rejection data and consultant feedback, here are the most common reasons applications fail.

• Invalid or Expired CPP: CPP more than 2 years old or not in WHO format. TMDA rejects these immediately.
• Missing Notarization/Apostille: All foreign documents must be notarized and apostilled. TMDA will not accept plain copies or simple notarization without apostille.
• Incorrect Reference Product for Bioequivalence: Your BE study must compare against the innovator product registered in Tanzania or a WHO PQ-listed comparator. Many manufacturers use the wrong reference product.
• Inadequate Stability Data: Zone II stability data (Mediterranean climate) is rejected. Zone IV (tropical, 30°C/75% RH) is required. Tanzania is hot and humid year-round.
• GMP Certificate Issues: Certificate must be current (usually within 3 years), cover your specific dosage form, and be properly legalized. Expired GMP = rejection.
• Product Sample Fails TMDA Laboratory Testing: TMDA will test your product. If it fails assay, impurities, or dissolution, registration is rejected. No appeal—just rejection.
• Labeling Errors: Your proposed labeling must include the TMDA registration number (once assigned), batch number, manufacturing date, expiry date, storage conditions, and preferably Swahili translation.
• Incomplete Dossier (Missing Modules): TMDA requires all 5 CTD modules. Missing Module 3 (quality) or Module 5 (clinical/BE) is an automatic deficiency.
• LAR Issues: If your local authorized representative doesn't have a licensed pharmacist on staff or a valid TMDA importer license, your application is rejected.

Post-Registration Obligations & Renewal

Getting the certificate is not the end. TMDA has ongoing requirements.

• Annual Retention Fees: Payable each year via the IMS portal. Late payment incurs penalties (10-25% of fee). Non-payment for 2+ years leads to deregistration.
• Variations: Any change to manufacturing site, formulation, specifications, packaging, or labeling requires TMDA notification. Major changes require a variation application with fees ($500-$2,000).
• Renewal: Initial registration is valid for 5 years. Renewal requires submission of updated dossiers, current GMP certificate, updated CPP, and evidence of continued compliance. Start the renewal process 6-9 months before expiry.
• Pharmacovigilance (PV): You must have a PV system to collect and report adverse events to TMDA. Periodic Safety Update Reports (PSURs) are required every 2 years. TMDA is increasingly focused on PV compliance.
• Post-Market Surveillance: TMDA may conduct market surveillance, sampling your product from Tanzanian pharmacies for testing. Failures can lead to product recalls or registration suspension.

Conclusion: Your TMDA Registration Strategy

Tanzania is a significant pharmaceutical market with growing demand, but success requires understanding TMDA's specific requirements, timelines, and local representation rules. The authority is professional and detail-oriented—they reward well-prepared dossiers and punish sloppiness.

Your TMDA registration checklist:

• ✓ Find a reputable Tanzanian LAR with a licensed pharmacist and valid TMDA importer license
• ✓ Execute and legalize a proper Power of Attorney (notarized + apostilled)
• ✓ Obtain a valid CPP (WHO format, less than 2 years old)
• ✓ Prepare your dossier in EAC CTD format with Zone IV stability data
• ✓ Consider the EAC Joint Assessment Procedure if targeting multiple EAC markets
• ✓ Budget $8,000-$15,000 per product for registration (all-in, standard generic)
• ✓ Plan for 8-12 months from submission to approval (standard pathway)
• ✓ Hire a specialized clearing agent for Dar es Salaam port clearance
• ✓ Decide whether Zanzibar registration is necessary for your business
• ✓ Build a strong relationship with your LAR—they're your legal face in Tanzania
• ✓ Stay current on annual fees and pharmacovigilance reporting

Is Tanzania worth the effort? For most pharmaceutical exporters, yes. The market is large (65+ million people), growing, and underserved. TMDA is a competent regulator with clear rules. And if you play the EAC harmonization card correctly, Tanzania becomes one stop in a six-country regional strategy.

The companies that win in Tanzania are the ones who treat the market seriously—proper dossiers, proper local partners, proper compliance. Cut corners, and TMDA will cut you out. Do it right, and Tanzania will reward you with consistent, growing demand for years to come.